Prognostic Value of Left Ventricular Kinetic Energy Assessed by 4D Flow CMR in Dilated Cardiomyopathy: A Prospective Multicenter Cohort Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Alterations in left ventricular intracavitary hemodynamics can occur early in the course of nonischemic dilated cardiomyopathy (DCM). However, the association between 4-dimensional (4D) flow cardiac magnetic resonance parameters and adverse outcomes in patients with DCM remains unclear. We aimed to evaluate whether 4D flow cardiac magnetic resonance parameters can predict adverse outcomes in patients with DCM. METHODS: In this multicenter prospective cohort study, 675 adult patients with DCM (mean age, 56 years; 399 men) from 3 medical centers and 80 age- and sex-matched healthy controls underwent 4D flow cardiac magnetic resonance. Left ventricular flow components and kinetic energy parameters were quantified. The primary end point was a composite of heart failure events, including heart failure–related death, unplanned heart failure hospitalization, or cardiac transplantation. RESULTS: During a median follow-up of 42 months, 58 patients (8.6%) experienced the primary end point. Compared with controls, patients with DCM exhibited reduced peak systolic kinetic energy normalized to EDV (KEi EDV ) and peak E-wave KEi EDV ; these differences were more pronounced in those who developed the primary end point. In univariable Cox regression, direct flow, residual volume, peak systolic KEi EDV , and peak E-wave KEi EDV were significant predictors of the primary end point (all P <0.05). After adjustment for left ventricular ejection fraction, NT-proBNP (N-terminal pro-B-type natriuretic peptide), extracellular volume fraction, extent of late gadolinium enhancement, peak systolic KEi EDV (adjusted hazard ratio, 0.39 [95% CI, 0.28–0.53]), and peak E-wave KEi EDV (adjusted hazard ratio, 0.35 [95% CI, 0.26–0.48]) remained independently associated with the primary end point (both P <0.001). Furthermore, these 2 kinetic energy parameters provided incremental prognostic value beyond clinical markers and conventional imaging markers for predicting the primary end point. CONCLUSIONS: In patients with DCM, decreased peak systolic KEi EDV and peak E-wave KEi EDV , as measured by 4D flow cardiac magnetic resonance, are independently associated with poor prognosis and provide incremental prognostic value for risk stratification beyond clinical and conventional imaging markers. REGISTRATION: URL: https://clinicaltrials.gov/ ; Unique Identifier: NCT07527715.
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7236068927
